Scage Future (SCAG) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 15, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Nov 12, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SCAG SEC filings page.
Scage Future (SCAG) reported $11.1M in revenue for fiscal year 2025, up 82.0% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
External financing is bridging a loss-making operation while short-term obligations remain the dominant balance-sheet pressure.
Revenue expansion took sales from$6.1M in FY2024 to$11.1M in FY2025, while gross margin reversed from positive to negative; added volume did not create a viable unit-level spread. SG&A reached$10.7M as operating losses widened to$13.4M , showing overhead absorption failed to turn added sales into operating leverage.
Reported liabilities of
FY2025 financing cash flow was
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Scage Future's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Scage Future held $20.4M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $5.9M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Scage Future scores 64/100 among other emerging companies.
Scage Future had 72M shares outstanding at the end of fiscal year 2025. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Scage Future scores 21/100 among other emerging companies.
Scage Future spent $1.5M on research and development in fiscal year 2025, which was 6.3% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Scage Future scores 26/100 among other emerging companies.
Scage Future reported revenue of $11.1M in fiscal year 2025, against $6.1M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Scage Future scores 95/100 among other emerging companies.
Scage Future's operations used $5.9M of cash in fiscal year 2025, against $6.2M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Scage Future scores 36/100 among other emerging companies.
Scage Future's cash, cash equivalents and investments came to $20.4M at the end of fiscal year 2025, against $27.4M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Scage Future scores 52/100 among other emerging companies.
Scage Future scores -3.95, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($16.0M) relative to total liabilities ($27.4M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Scage Future passes 2 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
Scage Future reported a net loss of $12.9M while operations used $5.9M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Scage Future reported an operating loss of $13.4M against $338K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
None of these metrics is reported for Q4 2025.
Cash & Balance Sheet
Scage Future held $91K in cash as of Q4 2025; long-term debt is not reported for that period.
Not reported for Q4 2025.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
None of these metrics is reported for Q4 2025.
SCAG Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, Interest Expense, Income Tax, Net Income, EPS (Basic), EPS (Diluted), Diluted Shares (Avg).
SCAG Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q4'2420-F |
|---|---|---|
| Total Assets | $26.5M+150.9% | $10.6M |
| Current Assets | $5.0M-41.4% | $8.6M |
| Cash & Equivalents | $91K-95.4% | $2.0M |
| Short-Term Investments | $0 | $0 |
| Inventory | $1.0M-39.2% | $1.7M |
| Accounts Receivable | $2.6M+28.7% | $2.0M |
| Long-Term Investments | $20.3M | $0 |
| Total Liabilities | $27.4M-25.0% | $36.6M |
| Current Liabilities | $25.4M+100.3% | $12.7M |
| Non-Current Liabilities | $2.0M+2227.4% | $87K |
| Total Equity | -$5.3M+79.7% | -$26.0M |
| Retained Earnings | -$40.2M-47.5% | -$27.3M |
Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.
SCAG Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.
SCAG Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Return on Equity, Return on Assets, Debt-to-Equity, Asset Turnover, FCF Margin.
Note: Shareholder equity is negative (-$5.3M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.20), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Where Scage Future Ranks
Frequently Asked Questions
What is Scage Future's annual revenue?
Scage Future (SCAG) reported $11.1M in total revenue for fiscal year 2025. This represents a 82.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Scage Future's revenue growing?
Scage Future (SCAG) revenue grew by 82.0% year-over-year, from $6.1M to $11.1M in fiscal year 2025.
Is Scage Future profitable?
No, Scage Future (SCAG) reported a net income of -$12.9M in fiscal year 2025.
What is Scage Future's EBITDA?
Scage Future (SCAG) had EBITDA of -$13.1M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Scage Future's gross margin?
Scage Future (SCAG) had a gross margin of -6.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Scage Future's free cash flow?
Scage Future (SCAG) recorded an outflow of $5.9M in free cash flow during fiscal year 2025. This represents a 5.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Scage Future's operating cash flow?
Scage Future (SCAG) recorded an outflow of $5.9M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Scage Future's total assets?
Scage Future (SCAG) had $26.5M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Scage Future's capital expenditures?
Scage Future (SCAG) invested $13K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Scage Future spend on research and development?
Scage Future (SCAG) invested $1.5M in research and development during fiscal year 2025.
What is Scage Future's current ratio?
Scage Future (SCAG) had a current ratio of 0.20 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Scage Future's return on assets (ROA)?
Scage Future (SCAG) had a return on assets of -48.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Scage Future's P/E ratio?
Scage Future (SCAG) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $16.0M as of Sep 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Scage Future's price-to-sales ratio?
Scage Future (SCAG) trades at 1.4x sales, its market capitalization divided by revenue of $11.1M revenue, FY2025. The market capitalization is $16.0M as of Sep 15, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
How does Scage Future's liquidity compare with its operating cash outflow?
At the end of fiscal year 2025, Scage Future (SCAG) held $20.4M in cash, cash equivalents and investments, and reported an operating cash outflow of $5.9M over that year. Dividing the one by the other, the reported balance equals about 42 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.
Why is Scage Future's debt-to-equity ratio negative or not reported?
Scage Future (SCAG) has negative shareholder equity of -$5.3M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Scage Future's Altman Z-Score?
Scage Future (SCAG) has an Altman Z-Score of -3.95, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Scage Future's Piotroski F-Score?
Scage Future (SCAG) has a Piotroski F-Score of 2 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Scage Future's earnings high quality?
Scage Future (SCAG) reported a net loss of $12.9M while operations used $5.9M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Scage Future cover its interest payments?
Scage Future (SCAG) reported an operating loss of $13.4M against $338K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Scage Future?
Scage Future (SCAG) scores 49 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.